Role of Body Composition in Patients with Resectable Pancreatic Cancer
Nutrients · 2024
DOI: 10.3390/nu16121834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Annarita Pecchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Department, Modena University Hospital, University of Modena and Reggio Emilia, 41124 Modena, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Body Composition, Sarcopenia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study investigates the role of body composition parameters in patients with pancreatic cancer undergoing surgical treatment. The research involved 88 patients diagnosed with pancreatic cancer who underwent surgery at the Modena Cancer Center between June 2015 and October 2023. Body composition parameters were obtained from CT scans performed before and after surgery. The percentage of sarcopenic patients at the time of diagnosis of pancreatic cancer is 56.82%. Of the patients who died between the first and second CT evaluated, 58% were sarcopenic, thus confirming the role of sarcopenia on outcome. The study found that all body composition parameters (TAMA, SMI, VFI, and SFI) demonstrated a trend towards reduction between two examinations, indicating an overall depletion in muscle and adipose tissue. We then evaluated the relationships between fat-related parameters (VFI, SFI and VSR) and survival outcomes: overall survival and progression-free survival. Cox univariate regression model show significant parameter related to outcomes was adipose tissue, specifically VFI. The study found that higher VFI levels were associated with greater survival rates. This research holds promise for advancing our understanding of the link between body composition and the prognosis of pancreatic cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiology Department, Modena University Hospital, University of Modena and Reggio Emilia, 41124 Modena, Italy.
- Division of Metabolic Diseases and Clinical Nutrition, Department of Specialistic Medicines, Modena University Hospital, 41124 Modena, Italy.
- Unit of Clinical Statistics, University Hospital of Modena, 41124 Modena, Italy.
- Oncology Department, Modena University Hospital, University of Modena and Reggio Emilia, 41124 Modena, Italy.
- Hepato-Bilio-Pancreatic Surgery and Liver Transplantation Unit, Modena University Hospital, University of Modena and Reggio Emilia, 41124 Modena, Italy.
ORCID-Profile: Massimo Dominici
Zitieren
APA
Pecchi, A., Valoriani, F., Cuoghi Costantini, R., Squecco, D., Spallanzani, A., D'Amico, R., Dominici, M., Di Benedetto, F., Torricelli, P., & Menozzi, R. (2024). Role of Body Composition in Patients with Resectable Pancreatic Cancer. Nutrients. https://doi.org/10.3390/nu16121834
Vancouver
Pecchi A, Valoriani F, Cuoghi Costantini R, Squecco D, Spallanzani A, D'Amico R, et al. Role of Body Composition in Patients with Resectable Pancreatic Cancer. Nutrients. 2024. doi:10.3390/nu16121834
BibTeX
@article{Pecchi2024,
author = {Pecchi, Annarita and Valoriani, Filippo and Cuoghi Costantini, Riccardo and Squecco, Denise and Spallanzani, Andrea and D'Amico, Roberto and Dominici, Massimo and Di Benedetto, Fabrizio and Torricelli, Pietro and Menozzi, Renata},
title = {Role of Body Composition in Patients with Resectable Pancreatic Cancer},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16121834}
}
EUVIMED